News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EU Extends Review Deadline for Solvay Pharmaceuticals, Inc., Abbott Laboratories (ABT) (JOBS) Deal



1/22/2010 6:43:29 AM

Bookmark and Share

Reuters -- EU regulators extended on Friday their review of U.S. drugmaker Abbott Laboratories' (ABT.N) plan to acquire Belgian peer Solvay Pharmaceuticals (SOLB.BR) after Abbott offered remedies to ease competition concerns.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES